In line with this, human genetic studies have found that loss-of-function mutations in ROS-producing enzymes predispose to IBD: patients (especially with very-early-onset IBD) carrying defective NOX2 (as in chronic granulomatous disease) or mutations in NOX1/DUOX2 often develop colitis (130–132). The gene discussed is CYBB; the disease is inflammatory bowel disease.